fluorodeoxyglucose f18 has been researched along with Left Ventricular Hypertrophy in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (21.43) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartenstein, P; Beetz, NL; Brunner, S; Grabmaier, U; Günther, L; Huber, B; Lehner, S; Todica, A; Zacherl, MJ | 1 |
Bézy, S; Claus, P; Cvijic, M; Degtiarova, G; Duchenne, J; Gheysens, O; Nuyts, J; Pagourelias, ED; Rega, F; Turco, A; Ünlü, S; Voigt, JU; Vunckx, K | 1 |
Brennan, KM; Gullberg, GT; Hernandez, AM; Huber, JS; Janabi, M; Murphy, ST; O'Neil, JP; Seo, Y; Zeng, GL | 1 |
Benz, V; Böhm, C; Dragun, D; Foryst-Ludwig, A; Gürgen, D; Kintscher, U; Kreissl, MC; Mai, K; Regitz-Zagrosek, V; Schubert, C; Sprang, C; Spranger, J; Stawowy, P; Thalke, B; Unger, T | 1 |
Canillas, F; Delgado-Baeza, E; Delgado-Martos, MJ; Fernández-Criado, Mdel C; Gómez de Diego, JJ; Martos-Rodríguez, A; Quintana-Villamandos, B; Sánchez-Hernández, JJ | 1 |
Aquino, SL; Fan, CM; Fischman, AJ; Halpern, EF; Kuester, LB | 1 |
Funabashi, N; Hasegawa, H; Komuro, I; Kuwabara, Y; Nakagawa, K; Shindo, S; Takano, H; Takeda, S; Toyozaki, T | 1 |
Handa, N; Komeda, M; Konishi, J; Magata, Y; Mukai, T; Nishina, T | 1 |
Haaparanta, M; Jula, A; Knuuti, MJ; Koivisto, VA; Laine, H; Luotolahti, M; Mäki, M; Nuutila, P; Ruotsalainen, U; Solin, O | 1 |
Bailey, DL; Boyd, HL; Camici, PG; Costa, DC; Gunn, RN; Karwatowski, SP; Marinho, NV | 1 |
Friemel, F; Merlet, P; Pouillard, F; Toraa, M | 1 |
Aronen, HJ; Hänninen, H; Janatuinen, T; Knuuti, J; Lauerma, K; Mäkelä, T; Mäkijärvi, MA; Niemi, P; Toivonen, L; Voipio-Pulkki, LM | 1 |
Andrén, B; Björntorp, P; Holmäng, A; Lind, L; Lithell, H; Sundström, J; Valind, S; Waldenström, A | 1 |
Hasegawa, S; Hori, M; Maruyama, A; Maruyama, K; Nishimura, T; Paul, AK; Xiuli, M; Yoshioka, J | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and Left Ventricular Hypertrophy
Article | Year |
---|---|
Myocardial insulin-mediated glucose uptake and left ventricular geometry.
Topics: Aged; Blood Glucose; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Heart; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Insulin; Male; Muscle, Skeletal; Myocardium; Tomography, Emission-Computed | 2001 |
Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
Topics: Aged; Cell Survival; Coronary Artery Disease; Exercise Test; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2002 |
12 other study(ies) available for fluorodeoxyglucose f18 and Left Ventricular Hypertrophy
Article | Year |
---|---|
Monitoring of Cardiac Remodeling in a Mouse Model of Pressure-Overload Left Ventricular Hypertrophy with [
Topics: Animals; Diastole; Disease Models, Animal; Fluorodeoxyglucose F18; Hypertrophy, Left Ventricular; Male; Mice, Inbred C57BL; Myocardium; Organ Size; Positron-Emission Tomography; Pressure; Stroke Volume; Ventricular Remodeling | 2018 |
Left Ventricular Remodeling Results in Homogenization of Myocardial Work Distribution.
Topics: Adaptation, Physiological; Animals; Cardiac Pacing, Artificial; Disease Models, Animal; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Hypertrophy, Left Ventricular; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sheep, Domestic; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Longitudinal evaluation of left ventricular substrate metabolism, perfusion, and dysfunction in the spontaneously hypertensive rat model of hypertrophy using small-animal PET/CT imaging.
Topics: Animals; Disease Models, Animal; Fatty Acids; Fatty Acids, Nonesterified; Fluorodeoxyglucose F18; Heart Ventricles; Hypertrophy, Left Ventricular; Insulin; Longitudinal Studies; Male; Multimodal Imaging; Myocardial Perfusion Imaging; Phenotype; Positron-Emission Tomography; Rats; Rats, Inbred SHR; Tomography, X-Ray Computed | 2013 |
Sex differences in physiological cardiac hypertrophy are associated with exercise-mediated changes in energy substrate availability.
Topics: Adipose Tissue; Animals; Blotting, Western; Calorimetry; Cardiomegaly; Echocardiography; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Glycogen; Hypertrophy, Left Ventricular; Lactic Acid; Lipolysis; Male; Mice; Mice, Inbred C57BL; Myocardium; Physical Conditioning, Animal; Positron-Emission Tomography; Radiopharmaceuticals; RNA; Running; Sex Characteristics | 2011 |
Early regression of left ventricular hypertrophy after treatment with esmolol in an experimental rat model of primary hypertension.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Hypertension; Hypertrophy, Left Ventricular; Male; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ultrasonography | 2013 |
Lipomatous hypertrophy of the interatrial septum: prevalence and features on fusion 18F fluorodeoxyglucose positron emission tomography/CT.
Topics: Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Heart Septum; Humans; Hypertrophy, Left Ventricular; Image Processing, Computer-Assisted; Lipoma; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Tomography, Spiral Computed | 2005 |
Images in cardiovascular medicine. Transition from left ventricular hypertrophy to massive fibrosis in the cardiac variant of Fabry disease.
Topics: Adult; Fabry Disease; Fibrosis; Fluorodeoxyglucose F18; Heart; Humans; Hypertrophy, Left Ventricular; Male; Myocardium; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2006 |
Quantitative FDG-uptake by positron emission tomography in progressive hypertrophy of rat hearts in vivo.
Topics: Animals; Fluorodeoxyglucose F18; Heart; Hypertrophy, Left Ventricular; Image Interpretation, Computer-Assisted; Metabolic Clearance Rate; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred Dahl | 2007 |
Insulin action on heart and skeletal muscle glucose uptake in essential hypertension.
Topics: Adult; Biological Transport, Active; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Image Processing, Computer-Assisted; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Myocardium; Oxygen Consumption; Tomography, Emission-Computed; Ventricular Function, Left | 1995 |
Non-invasive measurement of left ventricular volumes and function by gated positron emission tomography.
Topics: Coronary Disease; Deoxyglucose; Erythrocytes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Hypertrophy, Left Ventricular; Male; Oxygen Radioisotopes; Phantoms, Imaging; Sodium Pertechnetate Tc 99m; Stroke Volume; Tomography, Emission-Computed; Ventricular Function, Left | 1996 |
[Cardiac hypertrophy and coronary reserve in endurance athletes].
Topics: Adult; Analysis of Variance; Case-Control Studies; Coronary Circulation; Electrocardiography; Fluorodeoxyglucose F18; Humans; Hypertrophy, Left Ventricular; Oxygen Radioisotopes; Physical Endurance; Tomography, Emission-Computed | 1999 |
Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience.
Topics: Aged; Cardiotonic Agents; Coronary Disease; Dobutamine; Female; Fluorodeoxyglucose F18; Heart Function Tests; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Function, Left; Ventriculography, First-Pass | 2000 |